HK1138262A1 - Novel phosphodiesterase inhibitors - Google Patents
Novel phosphodiesterase inhibitorsInfo
- Publication number
- HK1138262A1 HK1138262A1 HK10103418.6A HK10103418A HK1138262A1 HK 1138262 A1 HK1138262 A1 HK 1138262A1 HK 10103418 A HK10103418 A HK 10103418A HK 1138262 A1 HK1138262 A1 HK 1138262A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compounds
- phosphodiesterase inhibitors
- novel phosphodiesterase
- novel
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90384907P | 2007-02-28 | 2007-02-28 | |
US94684907P | 2007-06-28 | 2007-06-28 | |
PCT/DK2008/000080 WO2008104175A2 (fr) | 2007-02-28 | 2008-02-26 | Nouveaux inhibiteurs de la phosphodiestérase |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1138262A1 true HK1138262A1 (en) | 2010-08-20 |
Family
ID=39415336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10103418.6A HK1138262A1 (en) | 2007-02-28 | 2010-04-07 | Novel phosphodiesterase inhibitors |
Country Status (22)
Country | Link |
---|---|
US (1) | US8338431B2 (fr) |
EP (1) | EP2114951B9 (fr) |
JP (1) | JP5501770B2 (fr) |
KR (1) | KR101571654B1 (fr) |
AU (1) | AU2008221121B2 (fr) |
BR (1) | BRPI0807749B8 (fr) |
CA (1) | CA2676933C (fr) |
CY (1) | CY1115227T1 (fr) |
DK (1) | DK2114951T3 (fr) |
ES (1) | ES2478670T3 (fr) |
HK (1) | HK1138262A1 (fr) |
HR (1) | HRP20140585T1 (fr) |
IL (1) | IL200153A (fr) |
MX (1) | MX2009009238A (fr) |
MY (1) | MY150075A (fr) |
NZ (1) | NZ578804A (fr) |
PL (1) | PL2114951T3 (fr) |
PT (1) | PT2114951E (fr) |
RS (1) | RS53407B (fr) |
RU (1) | RU2495043C2 (fr) |
SI (1) | SI2114951T1 (fr) |
WO (1) | WO2008104175A2 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2010335654B2 (en) | 2009-12-22 | 2015-04-09 | Leo Pharma A/S | Cutaneous composition comprising vitamin D analogue and a mixture of solvent and surfactants |
CN102770125B (zh) | 2009-12-22 | 2015-02-11 | 利奥制药有限公司 | 钙泊三醇一水化合物纳米晶体 |
BR112012015437A2 (pt) | 2009-12-22 | 2016-03-15 | Leo Pharma As | composição tópica substancialmente anidra de armazenamento estável |
SI3070091T1 (sl) * | 2010-06-24 | 2019-08-30 | Leo Pharma A/S | Derivati benzodioksola kot zaviralci fosfodiesteraze |
WO2013122855A1 (fr) * | 2012-02-14 | 2013-08-22 | University Of Rochester | Procédés d'augmentation du transport lymphatique |
BR112014029642A2 (pt) * | 2012-06-04 | 2017-06-27 | Chiesi Farm Spa | composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit |
US9855285B2 (en) | 2012-11-30 | 2018-01-02 | Leo Pharma A/S | Method of inhibiting the expression of IL-22 in activated T-cells |
CN106459081B (zh) * | 2014-06-23 | 2019-09-10 | 利奥制药有限公司 | 1,3-苯并二氧杂环戊烯杂环化合物的制备方法 |
US10160750B2 (en) | 2015-06-19 | 2018-12-25 | Bristol-Myers Squibb Company | Diamide macrocycles as factor XIa inhibitors |
AU2016369371C1 (en) * | 2015-12-18 | 2021-05-13 | UNION therapeutics A/S | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds |
JP6850887B2 (ja) * | 2016-12-12 | 2021-03-31 | レオ ファーマ アクティーゼルスカブ | 置換ピラゾロアゼピン−8−オンおよびそれらのホスホジエステラーゼ阻害剤としての使用 |
EP3551632B1 (fr) * | 2016-12-12 | 2024-06-12 | UNION therapeutics A/S | Pyrazoloazépin-4-ones substituées et leur utilisation en tant qu'inhibiteurs de phosphodiestérase |
RU2762279C2 (ru) * | 2016-12-12 | 2021-12-17 | Юнион Терапьютикс А/С | Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы |
CA3064033A1 (fr) | 2017-06-20 | 2018-12-27 | Leo Pharma A/S | Procedes pour la preparation de composes heterocycliques 1,3-benzodioxole |
TW201919682A (zh) | 2017-08-08 | 2019-06-01 | 西班牙商阿爾米雷爾有限公司 | 活化Nrf2路徑的新穎化合物 |
WO2019115776A1 (fr) | 2017-12-15 | 2019-06-20 | Leo Pharma A/S | Azétidine dihydrothiénopyridines substituées et leur utilisation en tant qu'inhibiteurs de phosphodiestérase |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9507297D0 (en) | 1995-04-07 | 1995-05-31 | Rh Ne Poulenc Rorer Limited | New composition of matter |
ATE325110T1 (de) * | 1995-05-19 | 2006-06-15 | Kyowa Hakko Kogyo Kk | Sauerstoff enthaltende heterocyclische verbindungen |
US6514996B2 (en) * | 1995-05-19 | 2003-02-04 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of benzofuran or benzodioxole |
DE69721526T2 (de) * | 1996-05-20 | 2004-04-08 | Darwin Discovery Ltd., Slough | Benzofuran carboxamide und ihre therapeutische anwendung |
JP3495376B2 (ja) * | 1996-08-28 | 2004-02-09 | ザ プロクター アンド ギャンブル カンパニー | スピロ環メタロプロテアーゼ阻害剤 |
CA2272327A1 (fr) | 1996-11-19 | 1998-05-28 | Kyowa Hakko Kogyo Co., Ltd. | Composes heterocycliques d'oxygene |
US6395738B1 (en) * | 1997-10-01 | 2002-05-28 | Kyowa Hakko Kogyo Co., Ltd. | Benzofuran derivatives |
DE19907038C2 (de) | 1999-02-19 | 2003-04-10 | Schott Glas | Transluzente oder opake Glaskeramik mit Hochquarz-Mischkristallen als vorherrschender Kristallphase und deren Verwendung |
-
2008
- 2008-02-26 MY MYPI20093168A patent/MY150075A/en unknown
- 2008-02-26 RS RS20140365A patent/RS53407B/en unknown
- 2008-02-26 US US12/528,649 patent/US8338431B2/en active Active
- 2008-02-26 AU AU2008221121A patent/AU2008221121B2/en active Active
- 2008-02-26 MX MX2009009238A patent/MX2009009238A/es active IP Right Grant
- 2008-02-26 WO PCT/DK2008/000080 patent/WO2008104175A2/fr active Application Filing
- 2008-02-26 EP EP08706922.5A patent/EP2114951B9/fr active Active
- 2008-02-26 NZ NZ578804A patent/NZ578804A/en unknown
- 2008-02-26 SI SI200831224T patent/SI2114951T1/sl unknown
- 2008-02-26 RU RU2009135810/04A patent/RU2495043C2/ru active
- 2008-02-26 JP JP2009551915A patent/JP5501770B2/ja active Active
- 2008-02-26 PT PT87069225T patent/PT2114951E/pt unknown
- 2008-02-26 PL PL08706922T patent/PL2114951T3/pl unknown
- 2008-02-26 CA CA2676933A patent/CA2676933C/fr active Active
- 2008-02-26 KR KR1020097018073A patent/KR101571654B1/ko active IP Right Grant
- 2008-02-26 DK DK08706922.5T patent/DK2114951T3/da active
- 2008-02-26 BR BRPI0807749A patent/BRPI0807749B8/pt active IP Right Grant
- 2008-02-26 ES ES08706922.5T patent/ES2478670T3/es active Active
-
2009
- 2009-07-30 IL IL200153A patent/IL200153A/en active IP Right Grant
-
2010
- 2010-04-07 HK HK10103418.6A patent/HK1138262A1/xx unknown
-
2014
- 2014-06-17 CY CY20141100437T patent/CY1115227T1/el unknown
- 2014-06-23 HR HRP20140585AT patent/HRP20140585T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0807749B8 (pt) | 2022-09-06 |
NZ578804A (en) | 2012-04-27 |
PT2114951E (pt) | 2014-07-17 |
CA2676933C (fr) | 2015-09-29 |
RU2009135810A (ru) | 2011-04-10 |
MY150075A (en) | 2013-11-29 |
MX2009009238A (es) | 2009-09-08 |
IL200153A0 (en) | 2010-04-15 |
AU2008221121A1 (en) | 2008-09-04 |
RU2495043C2 (ru) | 2013-10-10 |
IL200153A (en) | 2016-11-30 |
BRPI0807749A2 (pt) | 2014-06-17 |
BRPI0807749B1 (pt) | 2021-01-05 |
ES2478670T3 (es) | 2014-07-22 |
CY1115227T1 (el) | 2017-01-04 |
WO2008104175A2 (fr) | 2008-09-04 |
KR20090126252A (ko) | 2009-12-08 |
JP2010519332A (ja) | 2010-06-03 |
AU2008221121B2 (en) | 2013-10-03 |
CA2676933A1 (fr) | 2008-09-04 |
SI2114951T1 (sl) | 2014-08-29 |
KR101571654B1 (ko) | 2015-11-25 |
WO2008104175A3 (fr) | 2009-01-29 |
PL2114951T3 (pl) | 2014-10-31 |
DK2114951T3 (da) | 2014-06-23 |
EP2114951B1 (fr) | 2014-04-09 |
EP2114951A2 (fr) | 2009-11-11 |
HRP20140585T1 (hr) | 2014-09-12 |
EP2114951B9 (fr) | 2015-09-02 |
US8338431B2 (en) | 2012-12-25 |
RS53407B (en) | 2014-10-31 |
JP5501770B2 (ja) | 2014-05-28 |
US20100099688A1 (en) | 2010-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1138262A1 (en) | Novel phosphodiesterase inhibitors | |
MX2011009796A (es) | Inhibidores de la cinasa pi3. | |
MX2011011335A (es) | Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina. | |
WO2009155121A3 (fr) | Inhibiteurs de la pi3 kinase | |
TW200833675A (en) | Nicotinamide derivatives | |
SG179034A1 (en) | 2 -aminodihydro [1, 3] thiazines as bace 2 inhibitors for the treatment of diabetes | |
MX2011011854A (es) | Dihidropirimidinonas para uso como inhibidores de la bace2. | |
MX348422B (es) | Inhibidores de arginasa y sus aplicaciones terapeuticas. | |
MX2009010059A (es) | Derivados de quinolina para el tratamiento de enfermedades inflamatorias. | |
HK1149258A1 (en) | Compounds | |
NZ601483A (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
MY145795A (en) | Pyrazoline compounds | |
MY149512A (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
MX2009011802A (es) | Imidazoquinolinas con propiedades inmunomoduladoras. | |
WO2008145688A3 (fr) | Nouveaux composés | |
MX2007013624A (es) | Inhibidores de proteina cinasa. | |
TW200806300A (en) | New therapeutic combinations for the treatment of depression | |
GEP20135744B (en) | Quinuclidine carbonate derivatives and medicinal compositions containing the same | |
MX2010009022A (es) | Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso. | |
TW200639156A (en) | New compounds | |
MX2007004248A (es) | Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa. | |
HK1146049A1 (en) | Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1 | |
MX2012004311A (es) | Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes. | |
MX2009012613A (es) | Tiazoles substituidos por heteroarilo y su uso como agentes antivirales. | |
DE602008001725D1 (de) | 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus |